Use of Immunosuppressive Therapy in the Treatment of IgA-dominant Infection-related Glomerulonephritis

A 51-year-old Japanese man who experienced colon cancer recurrence following primary and metastatic lesion resection was hospitalized due to facial cellulitis with febrile neutropenia and purpura on his lower extremities after chemotherapy. It was complicated by rapidly progressive glomerulonephriti...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 61; no. 5; pp. 697 - 701
Main Authors Okumura, Motohiro, Sugihara, Shinnosuke, Seki, Kurumi, Nagaoka, Kanako, Okawa, Naoki, Ebihara, Masayuki, Inoue, Takahiro, Fukuda, Junko, Ohara, Mamiko, Imasawa, Toshiyuki, Kitamura, Hiroshi, Oda, Takashi, Suzuki, Tomo
Format Journal Article
LanguageEnglish
Published Japan The Japanese Society of Internal Medicine 01.03.2022
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A 51-year-old Japanese man who experienced colon cancer recurrence following primary and metastatic lesion resection was hospitalized due to facial cellulitis with febrile neutropenia and purpura on his lower extremities after chemotherapy. It was complicated by rapidly progressive glomerulonephritis. He was diagnosed with immunoglobulin A (IgA)-dominant endocapillary proliferative glomerulonephritis based on kidney histology. His glomeruli were positive for the nephritis-associated plasmin receptor, plasmin activity and galactose-deficient IgA1 (Gd-IgA1). A skin biopsy immunofluorescence study revealed IgA deposition within perivascular regions but no Gd-IgA1 deposition. The final diagnosis was IgA-dominant infection-related glomerulonephritis (IRGN). The patient's renal function returned to normal after receiving immunosuppressive therapy that consisted of a glucocorticoid and a cyclophosphamide. Immunosuppressive therapy should be considered in cases of IRGN if the patient's infection is completely under control.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Correspondence to Dr. Tomo Suzuki, suzuki.tomo@kameda.jp
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.7404-21